Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P1230: PET/CT IMAGING FOR RESP...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS

Bibliographic Details
Main Authors: T. Vassilakopoulos, A. Piperidou, Z. Mellios, E. Verigou, C. Kalpadakis, E. Katodritou, S. Papageorgiou, C. Chatzidimitriou, C. Giatra, T. Leonidopoulou, V. Xanthopoulos, S. Karakatsanis, G. Gainaru, E. Vrakidou, A. Koumarianou, E. Hatzimichael, E. Verrou, M. Tsirogianni, I. Drandakis, M. A. Lefaki, A. Liaskas, A. Kopsaftopoulou, P. Lampropoulou, N. Kanellias, P. Zikos, D. Liapi, G. Karianakis, D. Grentzelias, E. Papadaki, M. Siakantaris, P. Tsirigotis, F. Panitsas, E. Plata, M. Bakiri, I. Datseris, S. Chatziioannou, V. Prassopoulos, E. Skoura, M. Angelopoulou, A. Symeonidis, T. Karmiris, P. Rontogianni
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000847784.97005.7a
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000847784.97005.7a

Similar Items

  • P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP
    by: Theodoros Vassilakopoulos, et al.
    Published: (2023-08-01)
  • P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES
    by: T. Vassilakopoulos, et al.
    Published: (2022-06-01)
  • P1121: POSITRON EMISSION TOMOGRAPHY FOR FINAL RESPONSE ASSESSMENT TO RITUXIMAB-DOSE ADJUSTED EPOCH IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: WHO IS WORTHY TO BE IRRADIATED?
    by: Theodoros Vassilakopoulos, et al.
    Published: (2023-08-01)
  • PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
    by: Theodoros P. Vassilakopoulos, et al.
    Published: (2023-11-01)
  • Nonsteroidal anti-inflammatory drugs in the epoch of biological therapy
    by: A E Karateev, et al.
    Published: (2008-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs